Stay updated on Pembrolizumab for EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for EGFR+ NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Recruitment status is updated to 'No longer looking for participants', clarifying current availability. The page also adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision note to v3.6.0, along with a minor formatting tweak to the Intervention/Treatment label.
    Difference
    0.5%
    Check dated 2026-06-13T17:49:22.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now shows an updated revision label (v3.5.5) replacing the previous v3.5.4. This indicates a recent site or content update applied to the page.
    Difference
    0.1%
    Check dated 2026-06-06T14:08:38.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    A new site revision tag v3.5.4 was added, replacing the previous v3.5.3. This reflects an update to the site's build rather than changes to the study details displayed.
    Difference
    0.1%
    Check dated 2026-05-15T23:21:21.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page now displays revision v3.5.3, replacing the previous v3.5.2, indicating a maintenance/update to the website's version.
    Difference
    0.1%
    Check dated 2026-04-30T15:48:53.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and v3.5.0 removed, indicating a minor backend update to the site.
    Difference
    0.1%
    Check dated 2026-04-16T10:53:43.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    The page now shows a new site revision tag 'Revision: v3.5.0' instead of 'Revision: v3.4.3'. This is a minor version update with no impact on the study information.
    Difference
    0.1%
    Check dated 2026-03-18T18:22:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for EGFR+ NSCLC Clinical Trial page.